A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients with Progressive Supranuclear Palsy Who Participated in Study CN002003

Project: Research project

Project Details

Description

A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients with Progressive Supranuclear Palsy Who Participated in Study CN002003
StatusFinished
Effective start/end date10/11/183/31/20

Funding

  • BIOGEN INC

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.